AtriCure(ATRC) - 2025 Q3 - Quarterly Results

For immediate release October 29, 2025 2025 Financial Guidance Full year 2025 revenue is now projected to be approximately $532 million to $534 million, and management now expects full year 2025 Adjusted EBITDA of approximately $55 million to $57 million. Full year 2025 adjusted loss per share is expected to be in the range of $0.23 to $0.26. Additionally, management continues to expect cash flow generation for the full year 2025. Conference Call AtriCure will host a conference call at 4:30 p.m. Eastern Tim ...